nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—ABCB1—ovarian cancer	0.448	1	CbGaD
Etravirine—ABCB1—Topotecan—ovarian cancer	0.0703	0.199	CbGbCtD
Etravirine—ABCB1—Vinorelbine—ovarian cancer	0.0495	0.14	CbGbCtD
Etravirine—CYP3A4—Topotecan—ovarian cancer	0.0421	0.119	CbGbCtD
Etravirine—CYP2C9—Paclitaxel—ovarian cancer	0.0359	0.101	CbGbCtD
Etravirine—ABCB1—Paclitaxel—ovarian cancer	0.0348	0.0985	CbGbCtD
Etravirine—CYP3A4—Vinorelbine—ovarian cancer	0.0297	0.084	CbGbCtD
Etravirine—ABCB1—Docetaxel—ovarian cancer	0.0252	0.0712	CbGbCtD
Etravirine—CYP3A4—Paclitaxel—ovarian cancer	0.0209	0.059	CbGbCtD
Etravirine—ABCB1—Doxorubicin—ovarian cancer	0.0188	0.0531	CbGbCtD
Etravirine—CYP3A4—Docetaxel—ovarian cancer	0.0151	0.0427	CbGbCtD
Etravirine—CYP3A4—Doxorubicin—ovarian cancer	0.0112	0.0318	CbGbCtD
Etravirine—Rilpivirine—ABCB1—ovarian cancer	0.00162	1	CrCbGaD
Etravirine—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000306	0.00155	CcSEcCtD
Etravirine—Anaemia—Paclitaxel—ovarian cancer	0.000305	0.00155	CcSEcCtD
Etravirine—Erythema multiforme—Docetaxel—ovarian cancer	0.000304	0.00154	CcSEcCtD
Etravirine—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000303	0.00154	CcSEcCtD
Etravirine—Angioedema—Paclitaxel—ovarian cancer	0.000302	0.00153	CcSEcCtD
Etravirine—Eye disorder—Docetaxel—ovarian cancer	0.0003	0.00152	CcSEcCtD
Etravirine—Cardiac disorder—Docetaxel—ovarian cancer	0.000298	0.00151	CcSEcCtD
Etravirine—Vomiting—Topotecan—ovarian cancer	0.000298	0.00151	CcSEcCtD
Etravirine—Malaise—Paclitaxel—ovarian cancer	0.000298	0.00151	CcSEcCtD
Etravirine—Vertigo—Paclitaxel—ovarian cancer	0.000296	0.0015	CcSEcCtD
Etravirine—Syncope—Paclitaxel—ovarian cancer	0.000296	0.0015	CcSEcCtD
Etravirine—Rash—Topotecan—ovarian cancer	0.000295	0.0015	CcSEcCtD
Etravirine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000295	0.0015	CcSEcCtD
Etravirine—Dermatitis—Topotecan—ovarian cancer	0.000295	0.0015	CcSEcCtD
Etravirine—Headache—Topotecan—ovarian cancer	0.000293	0.00149	CcSEcCtD
Etravirine—Angiopathy—Docetaxel—ovarian cancer	0.000292	0.00148	CcSEcCtD
Etravirine—Vomiting—Melphalan—ovarian cancer	0.000291	0.00148	CcSEcCtD
Etravirine—Immune system disorder—Docetaxel—ovarian cancer	0.00029	0.00147	CcSEcCtD
Etravirine—Loss of consciousness—Paclitaxel—ovarian cancer	0.00029	0.00147	CcSEcCtD
Etravirine—Mediastinal disorder—Docetaxel—ovarian cancer	0.00029	0.00147	CcSEcCtD
Etravirine—Rash—Melphalan—ovarian cancer	0.000289	0.00147	CcSEcCtD
Etravirine—Dermatitis—Melphalan—ovarian cancer	0.000289	0.00146	CcSEcCtD
Etravirine—Asthenia—Vinorelbine—ovarian cancer	0.000287	0.00146	CcSEcCtD
Etravirine—Dry skin—Epirubicin—ovarian cancer	0.000287	0.00146	CcSEcCtD
Etravirine—Convulsion—Paclitaxel—ovarian cancer	0.000286	0.00145	CcSEcCtD
Etravirine—Hypertension—Paclitaxel—ovarian cancer	0.000285	0.00145	CcSEcCtD
Etravirine—Breast disorder—Epirubicin—ovarian cancer	0.000283	0.00144	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000282	0.00143	CcSEcCtD
Etravirine—Mental disorder—Docetaxel—ovarian cancer	0.000282	0.00143	CcSEcCtD
Etravirine—Anxiety—Paclitaxel—ovarian cancer	0.00028	0.00142	CcSEcCtD
Etravirine—Malnutrition—Docetaxel—ovarian cancer	0.00028	0.00142	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000279	0.00142	CcSEcCtD
Etravirine—Nausea—Topotecan—ovarian cancer	0.000278	0.00141	CcSEcCtD
Etravirine—Discomfort—Paclitaxel—ovarian cancer	0.000278	0.00141	CcSEcCtD
Etravirine—Gastritis—Epirubicin—ovarian cancer	0.000277	0.00141	CcSEcCtD
Etravirine—Dry mouth—Paclitaxel—ovarian cancer	0.000275	0.00139	CcSEcCtD
Etravirine—Diarrhoea—Vinorelbine—ovarian cancer	0.000274	0.00139	CcSEcCtD
Etravirine—Abdominal distension—Epirubicin—ovarian cancer	0.000273	0.00138	CcSEcCtD
Etravirine—Nausea—Melphalan—ovarian cancer	0.000272	0.00138	CcSEcCtD
Etravirine—Confusional state—Paclitaxel—ovarian cancer	0.000272	0.00138	CcSEcCtD
Etravirine—Eosinophilia—Epirubicin—ovarian cancer	0.000268	0.00136	CcSEcCtD
Etravirine—Infection—Paclitaxel—ovarian cancer	0.000268	0.00136	CcSEcCtD
Etravirine—Dry skin—Doxorubicin—ovarian cancer	0.000266	0.00135	CcSEcCtD
Etravirine—Pancreatitis—Epirubicin—ovarian cancer	0.000265	0.00135	CcSEcCtD
Etravirine—Shock—Paclitaxel—ovarian cancer	0.000265	0.00134	CcSEcCtD
Etravirine—Dizziness—Vinorelbine—ovarian cancer	0.000265	0.00134	CcSEcCtD
Etravirine—Nervous system disorder—Paclitaxel—ovarian cancer	0.000264	0.00134	CcSEcCtD
Etravirine—Angina pectoris—Epirubicin—ovarian cancer	0.000264	0.00134	CcSEcCtD
Etravirine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000264	0.00134	CcSEcCtD
Etravirine—Breast disorder—Doxorubicin—ovarian cancer	0.000262	0.00133	CcSEcCtD
Etravirine—Skin disorder—Paclitaxel—ovarian cancer	0.000262	0.00133	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000261	0.00132	CcSEcCtD
Etravirine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00026	0.00132	CcSEcCtD
Etravirine—Anaemia—Docetaxel—ovarian cancer	0.000259	0.00131	CcSEcCtD
Etravirine—Anorexia—Paclitaxel—ovarian cancer	0.000257	0.0013	CcSEcCtD
Etravirine—Gastritis—Doxorubicin—ovarian cancer	0.000257	0.0013	CcSEcCtD
Etravirine—Vomiting—Vinorelbine—ovarian cancer	0.000255	0.00129	CcSEcCtD
Etravirine—Rash—Vinorelbine—ovarian cancer	0.000252	0.00128	CcSEcCtD
Etravirine—Dermatitis—Vinorelbine—ovarian cancer	0.000252	0.00128	CcSEcCtD
Etravirine—Abdominal distension—Doxorubicin—ovarian cancer	0.000252	0.00128	CcSEcCtD
Etravirine—Headache—Vinorelbine—ovarian cancer	0.000251	0.00127	CcSEcCtD
Etravirine—Syncope—Docetaxel—ovarian cancer	0.000251	0.00127	CcSEcCtD
Etravirine—Eosinophilia—Doxorubicin—ovarian cancer	0.000248	0.00126	CcSEcCtD
Etravirine—Loss of consciousness—Docetaxel—ovarian cancer	0.000246	0.00125	CcSEcCtD
Etravirine—Pancreatitis—Doxorubicin—ovarian cancer	0.000246	0.00125	CcSEcCtD
Etravirine—Hyperglycaemia—Epirubicin—ovarian cancer	0.000244	0.00124	CcSEcCtD
Etravirine—Angina pectoris—Doxorubicin—ovarian cancer	0.000244	0.00124	CcSEcCtD
Etravirine—Insomnia—Paclitaxel—ovarian cancer	0.000244	0.00124	CcSEcCtD
Etravirine—Convulsion—Docetaxel—ovarian cancer	0.000242	0.00123	CcSEcCtD
Etravirine—Paraesthesia—Paclitaxel—ovarian cancer	0.000242	0.00123	CcSEcCtD
Etravirine—Hypertension—Docetaxel—ovarian cancer	0.000242	0.00123	CcSEcCtD
Etravirine—Somnolence—Paclitaxel—ovarian cancer	0.000239	0.00121	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000239	0.00121	CcSEcCtD
Etravirine—Nausea—Vinorelbine—ovarian cancer	0.000238	0.00121	CcSEcCtD
Etravirine—Renal failure—Epirubicin—ovarian cancer	0.000237	0.0012	CcSEcCtD
Etravirine—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000237	0.0012	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000237	0.0012	CcSEcCtD
Etravirine—Stomatitis—Epirubicin—ovarian cancer	0.000235	0.00119	CcSEcCtD
Etravirine—Conjunctivitis—Epirubicin—ovarian cancer	0.000235	0.00119	CcSEcCtD
Etravirine—Decreased appetite—Paclitaxel—ovarian cancer	0.000234	0.00119	CcSEcCtD
Etravirine—Dry mouth—Docetaxel—ovarian cancer	0.000233	0.00118	CcSEcCtD
Etravirine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000233	0.00118	CcSEcCtD
Etravirine—Fatigue—Paclitaxel—ovarian cancer	0.000232	0.00118	CcSEcCtD
Etravirine—Constipation—Paclitaxel—ovarian cancer	0.00023	0.00117	CcSEcCtD
Etravirine—Pain—Paclitaxel—ovarian cancer	0.00023	0.00117	CcSEcCtD
Etravirine—Confusional state—Docetaxel—ovarian cancer	0.00023	0.00117	CcSEcCtD
Etravirine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000228	0.00116	CcSEcCtD
Etravirine—Infection—Docetaxel—ovarian cancer	0.000227	0.00115	CcSEcCtD
Etravirine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000226	0.00115	CcSEcCtD
Etravirine—Shock—Docetaxel—ovarian cancer	0.000225	0.00114	CcSEcCtD
Etravirine—Nervous system disorder—Docetaxel—ovarian cancer	0.000224	0.00114	CcSEcCtD
Etravirine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000224	0.00113	CcSEcCtD
Etravirine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000222	0.00113	CcSEcCtD
Etravirine—Skin disorder—Docetaxel—ovarian cancer	0.000222	0.00113	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000221	0.00112	CcSEcCtD
Etravirine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00022	0.00112	CcSEcCtD
Etravirine—Renal failure—Doxorubicin—ovarian cancer	0.00022	0.00111	CcSEcCtD
Etravirine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000219	0.00111	CcSEcCtD
Etravirine—Stomatitis—Doxorubicin—ovarian cancer	0.000218	0.0011	CcSEcCtD
Etravirine—Anorexia—Docetaxel—ovarian cancer	0.000218	0.0011	CcSEcCtD
Etravirine—Conjunctivitis—Doxorubicin—ovarian cancer	0.000217	0.0011	CcSEcCtD
Etravirine—Hepatitis—Epirubicin—ovarian cancer	0.000217	0.0011	CcSEcCtD
Etravirine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000216	0.00109	CcSEcCtD
Etravirine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000214	0.00109	CcSEcCtD
Etravirine—Connective tissue disorder—Epirubicin—ovarian cancer	0.000213	0.00108	CcSEcCtD
Etravirine—Body temperature increased—Paclitaxel—ovarian cancer	0.000213	0.00108	CcSEcCtD
Etravirine—Abdominal pain—Paclitaxel—ovarian cancer	0.000213	0.00108	CcSEcCtD
Etravirine—Urethral disorder—Epirubicin—ovarian cancer	0.000212	0.00108	CcSEcCtD
Etravirine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000211	0.00107	CcSEcCtD
Etravirine—Insomnia—Docetaxel—ovarian cancer	0.000206	0.00105	CcSEcCtD
Etravirine—Paraesthesia—Docetaxel—ovarian cancer	0.000205	0.00104	CcSEcCtD
Etravirine—Erythema multiforme—Epirubicin—ovarian cancer	0.000205	0.00104	CcSEcCtD
Etravirine—Somnolence—Docetaxel—ovarian cancer	0.000203	0.00103	CcSEcCtD
Etravirine—Eye disorder—Epirubicin—ovarian cancer	0.000203	0.00103	CcSEcCtD
Etravirine—Cardiac disorder—Epirubicin—ovarian cancer	0.000201	0.00102	CcSEcCtD
Etravirine—Hepatitis—Doxorubicin—ovarian cancer	0.000201	0.00102	CcSEcCtD
Etravirine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.0002	0.00101	CcSEcCtD
Etravirine—Decreased appetite—Docetaxel—ovarian cancer	0.000198	0.00101	CcSEcCtD
Etravirine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000198	0.00101	CcSEcCtD
Etravirine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000198	0.001	CcSEcCtD
Etravirine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000197	0.001	CcSEcCtD
Etravirine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000197	0.001	CcSEcCtD
Etravirine—Fatigue—Docetaxel—ovarian cancer	0.000197	0.000999	CcSEcCtD
Etravirine—Angiopathy—Epirubicin—ovarian cancer	0.000197	0.000998	CcSEcCtD
Etravirine—Urethral disorder—Doxorubicin—ovarian cancer	0.000197	0.000997	CcSEcCtD
Etravirine—Immune system disorder—Epirubicin—ovarian cancer	0.000196	0.000993	CcSEcCtD
Etravirine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000195	0.000991	CcSEcCtD
Etravirine—Pain—Docetaxel—ovarian cancer	0.000195	0.00099	CcSEcCtD
Etravirine—Constipation—Docetaxel—ovarian cancer	0.000195	0.00099	CcSEcCtD
Etravirine—Asthenia—Paclitaxel—ovarian cancer	0.000193	0.00098	CcSEcCtD
Etravirine—Mental disorder—Epirubicin—ovarian cancer	0.00019	0.000963	CcSEcCtD
Etravirine—Erythema multiforme—Doxorubicin—ovarian cancer	0.00019	0.000962	CcSEcCtD
Etravirine—Malnutrition—Epirubicin—ovarian cancer	0.000189	0.000957	CcSEcCtD
Etravirine—Feeling abnormal—Docetaxel—ovarian cancer	0.000188	0.000954	CcSEcCtD
Etravirine—Eye disorder—Doxorubicin—ovarian cancer	0.000187	0.000951	CcSEcCtD
Etravirine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000187	0.000947	CcSEcCtD
Etravirine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000186	0.000944	CcSEcCtD
Etravirine—Flatulence—Epirubicin—ovarian cancer	0.000186	0.000943	CcSEcCtD
Etravirine—Tension—Epirubicin—ovarian cancer	0.000185	0.000939	CcSEcCtD
Etravirine—Diarrhoea—Paclitaxel—ovarian cancer	0.000184	0.000935	CcSEcCtD
Etravirine—Nervousness—Epirubicin—ovarian cancer	0.000183	0.00093	CcSEcCtD
Etravirine—Angiopathy—Doxorubicin—ovarian cancer	0.000182	0.000923	CcSEcCtD
Etravirine—Immune system disorder—Doxorubicin—ovarian cancer	0.000181	0.000919	CcSEcCtD
Etravirine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000181	0.000917	CcSEcCtD
Etravirine—Abdominal pain—Docetaxel—ovarian cancer	0.00018	0.000916	CcSEcCtD
Etravirine—Body temperature increased—Docetaxel—ovarian cancer	0.00018	0.000916	CcSEcCtD
Etravirine—Dizziness—Paclitaxel—ovarian cancer	0.000178	0.000904	CcSEcCtD
Etravirine—Vision blurred—Epirubicin—ovarian cancer	0.000178	0.000902	CcSEcCtD
Etravirine—Mental disorder—Doxorubicin—ovarian cancer	0.000176	0.000891	CcSEcCtD
Etravirine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000175	0.000888	CcSEcCtD
Etravirine—Malnutrition—Doxorubicin—ovarian cancer	0.000175	0.000886	CcSEcCtD
Etravirine—Anaemia—Epirubicin—ovarian cancer	0.000174	0.000885	CcSEcCtD
Etravirine—Flatulence—Doxorubicin—ovarian cancer	0.000172	0.000873	CcSEcCtD
Etravirine—Tension—Doxorubicin—ovarian cancer	0.000171	0.000869	CcSEcCtD
Etravirine—Vomiting—Paclitaxel—ovarian cancer	0.000171	0.000869	CcSEcCtD
Etravirine—Malaise—Epirubicin—ovarian cancer	0.00017	0.000863	CcSEcCtD
Etravirine—Rash—Paclitaxel—ovarian cancer	0.00017	0.000862	CcSEcCtD
Etravirine—Dermatitis—Paclitaxel—ovarian cancer	0.00017	0.000861	CcSEcCtD
Etravirine—Nervousness—Doxorubicin—ovarian cancer	0.00017	0.00086	CcSEcCtD
Etravirine—Vertigo—Epirubicin—ovarian cancer	0.00017	0.00086	CcSEcCtD
Etravirine—Syncope—Epirubicin—ovarian cancer	0.000169	0.000858	CcSEcCtD
Etravirine—Headache—Paclitaxel—ovarian cancer	0.000169	0.000856	CcSEcCtD
Etravirine—Hypersensitivity—Docetaxel—ovarian cancer	0.000168	0.000853	CcSEcCtD
Etravirine—Loss of consciousness—Epirubicin—ovarian cancer	0.000166	0.000841	CcSEcCtD
Etravirine—Vision blurred—Doxorubicin—ovarian cancer	0.000165	0.000835	CcSEcCtD
Etravirine—Asthenia—Docetaxel—ovarian cancer	0.000164	0.000831	CcSEcCtD
Etravirine—Convulsion—Epirubicin—ovarian cancer	0.000163	0.000829	CcSEcCtD
Etravirine—Hypertension—Epirubicin—ovarian cancer	0.000163	0.000826	CcSEcCtD
Etravirine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000162	0.000822	CcSEcCtD
Etravirine—Anaemia—Doxorubicin—ovarian cancer	0.000161	0.000819	CcSEcCtD
Etravirine—Anxiety—Epirubicin—ovarian cancer	0.00016	0.000812	CcSEcCtD
Etravirine—Nausea—Paclitaxel—ovarian cancer	0.00016	0.000812	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00016	0.000809	CcSEcCtD
Etravirine—Discomfort—Epirubicin—ovarian cancer	0.000159	0.000805	CcSEcCtD
Etravirine—Malaise—Doxorubicin—ovarian cancer	0.000157	0.000799	CcSEcCtD
Etravirine—Dry mouth—Epirubicin—ovarian cancer	0.000157	0.000797	CcSEcCtD
Etravirine—Vertigo—Doxorubicin—ovarian cancer	0.000157	0.000796	CcSEcCtD
Etravirine—Syncope—Doxorubicin—ovarian cancer	0.000157	0.000794	CcSEcCtD
Etravirine—Diarrhoea—Docetaxel—ovarian cancer	0.000156	0.000792	CcSEcCtD
Etravirine—Confusional state—Epirubicin—ovarian cancer	0.000155	0.000788	CcSEcCtD
Etravirine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000153	0.000778	CcSEcCtD
Etravirine—Infection—Epirubicin—ovarian cancer	0.000153	0.000776	CcSEcCtD
Etravirine—Shock—Epirubicin—ovarian cancer	0.000151	0.000769	CcSEcCtD
Etravirine—Convulsion—Doxorubicin—ovarian cancer	0.000151	0.000767	CcSEcCtD
Etravirine—Nervous system disorder—Epirubicin—ovarian cancer	0.000151	0.000766	CcSEcCtD
Etravirine—Dizziness—Docetaxel—ovarian cancer	0.000151	0.000766	CcSEcCtD
Etravirine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000151	0.000765	CcSEcCtD
Etravirine—Hypertension—Doxorubicin—ovarian cancer	0.000151	0.000765	CcSEcCtD
Etravirine—Skin disorder—Epirubicin—ovarian cancer	0.00015	0.000759	CcSEcCtD
Etravirine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000149	0.000755	CcSEcCtD
Etravirine—Anxiety—Doxorubicin—ovarian cancer	0.000148	0.000751	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000148	0.000749	CcSEcCtD
Etravirine—Discomfort—Doxorubicin—ovarian cancer	0.000147	0.000745	CcSEcCtD
Etravirine—Anorexia—Epirubicin—ovarian cancer	0.000147	0.000745	CcSEcCtD
Etravirine—Dry mouth—Doxorubicin—ovarian cancer	0.000145	0.000737	CcSEcCtD
Etravirine—Vomiting—Docetaxel—ovarian cancer	0.000145	0.000736	CcSEcCtD
Etravirine—Rash—Docetaxel—ovarian cancer	0.000144	0.00073	CcSEcCtD
Etravirine—Dermatitis—Docetaxel—ovarian cancer	0.000144	0.00073	CcSEcCtD
Etravirine—Confusional state—Doxorubicin—ovarian cancer	0.000144	0.000729	CcSEcCtD
Etravirine—Headache—Docetaxel—ovarian cancer	0.000143	0.000726	CcSEcCtD
Etravirine—Infection—Doxorubicin—ovarian cancer	0.000142	0.000718	CcSEcCtD
Etravirine—Shock—Doxorubicin—ovarian cancer	0.00014	0.000711	CcSEcCtD
Etravirine—Nervous system disorder—Doxorubicin—ovarian cancer	0.00014	0.000709	CcSEcCtD
Etravirine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000139	0.000708	CcSEcCtD
Etravirine—Insomnia—Epirubicin—ovarian cancer	0.000139	0.000707	CcSEcCtD
Etravirine—Skin disorder—Doxorubicin—ovarian cancer	0.000138	0.000702	CcSEcCtD
Etravirine—Paraesthesia—Epirubicin—ovarian cancer	0.000138	0.000702	CcSEcCtD
Etravirine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000138	0.000699	CcSEcCtD
Etravirine—Somnolence—Epirubicin—ovarian cancer	0.000137	0.000695	CcSEcCtD
Etravirine—Anorexia—Doxorubicin—ovarian cancer	0.000136	0.000689	CcSEcCtD
Etravirine—Nausea—Docetaxel—ovarian cancer	0.000136	0.000688	CcSEcCtD
Etravirine—Decreased appetite—Epirubicin—ovarian cancer	0.000134	0.000679	CcSEcCtD
Etravirine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000133	0.000674	CcSEcCtD
Etravirine—Fatigue—Epirubicin—ovarian cancer	0.000133	0.000674	CcSEcCtD
Etravirine—Pain—Epirubicin—ovarian cancer	0.000132	0.000668	CcSEcCtD
Etravirine—Constipation—Epirubicin—ovarian cancer	0.000132	0.000668	CcSEcCtD
Etravirine—Insomnia—Doxorubicin—ovarian cancer	0.000129	0.000654	CcSEcCtD
Etravirine—Paraesthesia—Doxorubicin—ovarian cancer	0.000128	0.000649	CcSEcCtD
Etravirine—Feeling abnormal—Epirubicin—ovarian cancer	0.000127	0.000644	CcSEcCtD
Etravirine—Somnolence—Doxorubicin—ovarian cancer	0.000127	0.000643	CcSEcCtD
Etravirine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000126	0.000639	CcSEcCtD
Etravirine—Decreased appetite—Doxorubicin—ovarian cancer	0.000124	0.000628	CcSEcCtD
Etravirine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000123	0.000624	CcSEcCtD
Etravirine—Fatigue—Doxorubicin—ovarian cancer	0.000123	0.000623	CcSEcCtD
Etravirine—Pain—Doxorubicin—ovarian cancer	0.000122	0.000618	CcSEcCtD
Etravirine—Constipation—Doxorubicin—ovarian cancer	0.000122	0.000618	CcSEcCtD
Etravirine—Abdominal pain—Epirubicin—ovarian cancer	0.000122	0.000618	CcSEcCtD
Etravirine—Body temperature increased—Epirubicin—ovarian cancer	0.000122	0.000618	CcSEcCtD
Etravirine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000117	0.000596	CcSEcCtD
Etravirine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000117	0.000591	CcSEcCtD
Etravirine—Hypersensitivity—Epirubicin—ovarian cancer	0.000113	0.000576	CcSEcCtD
Etravirine—Abdominal pain—Doxorubicin—ovarian cancer	0.000113	0.000571	CcSEcCtD
Etravirine—Body temperature increased—Doxorubicin—ovarian cancer	0.000113	0.000571	CcSEcCtD
Etravirine—Asthenia—Epirubicin—ovarian cancer	0.00011	0.000561	CcSEcCtD
Etravirine—Diarrhoea—Epirubicin—ovarian cancer	0.000105	0.000535	CcSEcCtD
Etravirine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000105	0.000533	CcSEcCtD
Etravirine—Asthenia—Doxorubicin—ovarian cancer	0.000102	0.000519	CcSEcCtD
Etravirine—Dizziness—Epirubicin—ovarian cancer	0.000102	0.000517	CcSEcCtD
Etravirine—Vomiting—Epirubicin—ovarian cancer	9.79e-05	0.000497	CcSEcCtD
Etravirine—Diarrhoea—Doxorubicin—ovarian cancer	9.75e-05	0.000495	CcSEcCtD
Etravirine—Rash—Epirubicin—ovarian cancer	9.71e-05	0.000493	CcSEcCtD
Etravirine—Dermatitis—Epirubicin—ovarian cancer	9.7e-05	0.000492	CcSEcCtD
Etravirine—Headache—Epirubicin—ovarian cancer	9.65e-05	0.000489	CcSEcCtD
Etravirine—Dizziness—Doxorubicin—ovarian cancer	9.42e-05	0.000478	CcSEcCtD
Etravirine—Nausea—Epirubicin—ovarian cancer	9.15e-05	0.000464	CcSEcCtD
Etravirine—Vomiting—Doxorubicin—ovarian cancer	9.06e-05	0.00046	CcSEcCtD
Etravirine—Rash—Doxorubicin—ovarian cancer	8.98e-05	0.000456	CcSEcCtD
Etravirine—Dermatitis—Doxorubicin—ovarian cancer	8.97e-05	0.000455	CcSEcCtD
Etravirine—Headache—Doxorubicin—ovarian cancer	8.93e-05	0.000453	CcSEcCtD
Etravirine—Nausea—Doxorubicin—ovarian cancer	8.46e-05	0.000429	CcSEcCtD
